Shir Jing Ho (Shir-Jing Ho)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

Acute Myeloid Leukemia

Multiple Myeloma

Catheter Ablation

Resistance Training

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

European journal of clinical pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Maciej Tatarczuch, Katharine Louise Lewis, Ashray Gunjur, Briony Shaw, Limei Michelle Poon, Erin Paul, Matthew Ku, Mark Wong, Sylvia S Y Ai, Ashley Beekman, Pietro R Di Ciaccio, Michael Krigstein, Joel C Wight, Caitlin Coombes, Michael Gilbertson, Amanda Tey, Jake Shortt, Chandramouli Nagarajan, Dipti Talaulikar, Nada Hamad, Sumita Ratnasingam, Shir Jing Ho, Tara Cochrane, Eliza A Hawkes, Chan Yoon Y Cheah, Stephen Samuel Opat, Gareth Peter Gregory
Sequential high-dose methotrexate and cytarabine administration improves outcomes in real-world patients with primary central nervous system lymphoma: A report from the Australasian Lymphoma Alliance. EJHaem 5 (4) (2024)
Maciej Tatarczuch, Katharine Louise Lewis, Ashray Gunjur, Briony Shaw, Limei Michelle Poon, Erin Paul, Matthew Ku, Mark Wong, Sylvia S Y Ai, Ashley Beekman, Pietro R Di Ciaccio, Michael Krigstein, Joel C Wight, Caitlin Coombes, Michael Gilbertson, Amanda Tey, Jake Shortt, Chandramouli Nagarajan, Dipti Talaulikar, Nada Hamad, Sumita Ratnasingam, Shir Jing Ho, Tara Cochrane, Eliza A Hawkes, Chan Yoon Y Cheah, Stephen Samuel Opat, Gareth Peter Gregory
Sequential high-dose methotrexate and cytarabine administration improves outcomes in real-world patients with primary central nervous system lymphoma: A report from the Australasian Lymphoma Alliance. EJHaem 5 (4) (2024)
Stephen Samuel Opat, Alessandra Tedeschi, Bei Hu, Kim M Linton, Pamela McKay, Sophie Leitch, Morton Coleman, Pier Luigi Luigi Zinzani, Jie Jin, Mingyuan Sun, Magdalena Sobieraj-Teague, Peter J Browett, Xiaoyan Ke, Catherine Thieblemont, Kirit M Ardeshna, Fontanet Bijou, Patricia A Walker, Eliza A Hawkes, Shir Jing Ho, Ke-Shu Zhou, Zhiyu Liang, Jianfeng Xu, Chris Tankersley, Richard Delarue, Melannie Co, Judith Trotman
Safety and efficacy of zanubrutinib in relapsed/refractory marginal zone lymphoma: final analysis of the MAGNOLIA study. Blood advances (2023)
Emmanuel J Favaloro, Joanne Clifford, Emma Leitinger, Michael Parker, Pauline Sung, Sanjeev Daya Chunilal, Huyen A Tran, Geoffrey W Kershaw, Suki Fu, Freda H Passam, Monica Ahuja, Shir Jing Ho, Elizabeth Duncan, Olivia Yacoub, Chee Wee Tan, Lisa Kaminskis, Natasha Modica, Dominic Pepperell, Leanne Ballard, Lisa Clarke, Christine Shu Mei Lee, Elizabeth E Gardiner, Philip Young-Ill Choi, Ibrahim Tohidi-Esfahani, Robert J Bird, Timothy Brighton, Vivien M Y Chen
Assessment of immunological anti-platelet factor 4 antibodies for vaccine-induced thrombotic thrombocytopenia (VITT) in a large Australian cohort: A multicenter study comprising 1284 patients. Journal of thrombosis and haemostasis : JTH 20 (12) (2022)
Christa Ellen Nath, Andrew Grigg, Sebastian P A Rosser, Jane Estell, Elizabeth Newman, Campbell Tiley, Sundra Ramanathan, Shir Jing Ho, Stephen Larsen, John Gibson, Peter Presgrave, Peter John Shaw, Judith Trotman
Challenges associated with test dose pharmacokinetic predictions of high dose melphalan exposure in patients with multiple myeloma. European journal of clinical pharmacology 78 (12) (2022)
Nizar J Bahlis, Rachid Baz, Simon J Harrison, Hang Quach, Shir Jing Ho, Annette Juul Vangsted, Torben Plesner, Phillipe Moreau, Simon D Gibbs, Sheryl Coppola, Xiaoqing Yang, Abdullah Al Masud, Jeremy A Ross, Orlando Bueno, Jonathan L Kaufman
Phase I Study of Venetoclax Plus Daratumumab and Dexamethasone, With or Without Bortezomib, in Patients With Relapsed or Refractory Multiple Myeloma With and Without t(11;14). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (32) (2021)